Lataa...
Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment
BACKGROUND AND OBJECTIVE: Insulin degludec is a basal insulin with a slow and distinct absorption mechanism resulting in an ultra-long, flat, and stable pharmacokinetic profile in patients with diabetes mellitus. The aim of this study was to examine the effect of hepatic impairment on the single-dos...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3899454/ https://ncbi.nlm.nih.gov/pubmed/24277680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0154-1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|